{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "43689-0067",
      "generic_name": "ATROPA BELLADONNA, CAPSICUM, HYPERICUM PERFORATUM WHOLE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE",
      "labeler_name": "The Magni Group, Inc. dba Magnilife",
      "brand_name": "Magnilife Leg and Back Pain Relief",
      "active_ingredients": [
        {
          "name": "ATROPA BELLADONNA",
          "strength": "3 [hp_X]/113g"
        },
        {
          "name": "CAPSICUM",
          "strength": "3 [hp_X]/113g"
        },
        {
          "name": "HYPERICUM PERFORATUM WHOLE",
          "strength": "3 [hp_X]/113g"
        },
        {
          "name": "MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE",
          "strength": "6 [hp_X]/113g"
        },
        {
          "name": "TOXICODENDRON PUBESCENS LEAF",
          "strength": "6 [hp_X]/113g"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "43689-0067-1",
          "description": "113 g in 1 JAR (43689-0067-1)",
          "marketing_start_date": "20260925",
          "sample": false
        },
        {
          "package_ndc": "43689-0067-2",
          "description": "1 JAR in 1 BOX, UNIT-DOSE (43689-0067-2)  / 113 g in 1 JAR",
          "marketing_start_date": "20260925",
          "sample": false
        },
        {
          "package_ndc": "43689-0067-3",
          "description": "2 JAR in 1 BOX, UNIT-DOSE (43689-0067-3)  / 113 g in 1 JAR",
          "marketing_start_date": "20260925",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "UNAPPROVED HOMEOPATHIC",
      "dosage_form": "CREAM",
      "spl_id": "5c510c74-dd63-fff4-e063-6294a90a3ec2",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "TOPICAL"
      ],
      "marketing_start_date": "20260925",
      "product_id": "43689-0067_5c510c74-dd63-fff4-e063-6294a90a3ec2",
      "brand_name_base": "Magnilife Leg and Back Pain Relief",
      "pharm_class": [
        "Allergens [CS]",
        "Calculi Dissolution Agent [EPC]",
        "Cell-mediated Immunity [PE]",
        "Dietary Proteins [CS]",
        "Increased Histamine Release [PE]",
        "Increased Large Intestinal Motility [PE]",
        "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
        "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
        "Magnesium Ion Exchange Activity [MoA]",
        "Non-Standardized Food Allergenic Extract [EPC]",
        "Non-Standardized Plant Allergenic Extract [EPC]",
        "Osmotic Activity [MoA]",
        "Osmotic Laxative [EPC]",
        "Plant Proteins [CS]",
        "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
        "Vegetable Proteins [CS]"
      ]
    }
  ]
}